Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 04, 2022

SELL
$13.42 - $23.38 $114,727 - $199,875
-8,549 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$12.78 - $23.74 $109,256 - $202,953
8,549 New
8,549 $203,000
Q3 2019

Nov 06, 2019

SELL
$15.84 - $30.01 $135,416 - $256,555
-8,549 Closed
0 $0
Q2 2019

Jul 25, 2019

BUY
$17.38 - $26.88 $148,581 - $229,797
8,549 New
8,549 $230,000

Others Institutions Holding MGTX

About MeiraGTx Holdings plc


  • Ticker MGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,010,700
  • Market Cap $288M
  • Description
  • MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...
More about MGTX
Track This Portfolio

Track Financial Advisory Service, Inc. Portfolio

Follow Financial Advisory Service, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Advisory Service, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Advisory Service, Inc. with notifications on news.